Equibles does not estimate personal net worth.
Samar Kamdar was last confirmed as CFO at biote Corp. (BTMD) in a filing dated April 14, 2023. biote Corp. reported in an 8-K filed August 24, 2022 that Samar Kamdar was appointed Chief Financial Officer, effective August 24, 2022. The proxy statement of biote Corp. reports total compensation of $762,890 for Samar Kamdar in fiscal 2022, including a base salary of $118,462. Disclosed compensation is on record for 2 fiscal years. Samar Kamdar has spoken on 2 earnings calls across 1 company, most recently for biote Corp. on November 7, 2023. The companies whose calls Samar Kamdar spoke on are classified in the Healthcare sector.
“On August 24, 2022, biote Corp. (the "Company") announced the appointment of Samar Kamdar as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.”
“Third quarter revenue increased 8.5% year-over-year to $45.6 million, with product revenue up 7.8% and service revenue up 83.3%. Within product revenue, procedure revenue increased 7.4% and supplements revenue increased 5.1% year-over-year.”
“Revenue for the second quarter increased 19.1% from the prior year period to $49.3 million, reflecting 9.8% growth in procedure revenue and 52.8% growth in dietary supplement revenue.”
Start not stated–2023-04-14
Last confirmed by a filing; no departure on record
BTMD
Medical Care Facilities · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | biote Corp. (BTMD) | Chief Financial Officer | $118,462 | $762,890 |
| 2021 | biote Corp. (BTMD) | Chief Financial Officer | — | — |
